98%
921
2 minutes
20
Purpose: To investigate myopic choroidal neovascularization (mCNV) by fluorescein angiography (FA), spectral-domain optical coherence tomography (SD-OCT), near-infrared (NIR) reflectance, and autofluorescence (AF).
Methods: This retrospective study included 65 eyes of 62 Caucasian patients with a mean age of 66.72 years (95% confidence interval [CI] 63-70 years) and a mean refraction of -9.72 diopters (95% CI -8.74 to -10.70 diopters).
Results: Most of the mCNV cases were foveal-juxtafoveal (60/65, 92.3%), with thickening of the corresponding retina (62/65, 95.3%) and leakage on FA (44/65, 67.6%). No retinal fluid was detectable in 32 (49.2%) eyes and there was no hemorrhage in 25 (38.4%) eyes. Papillary chorioretinal atrophy was evident in 58 (89.2%), a shadowing effect in 48 (73.8%), and an epiretinal membrane in 38 (58.4%) eyes. If an area of macular chorioretinal atrophy was present, mCNV frequently developed adjacent to it and was hyperfluorescent rather than with leakage (P⩽0.001). In eyes with edema or hemorrhage, hyper-reflective foci were more frequent (P⩽0.005). NIR and AF features were indeterminable in 19 (29.2%) and 27 (41.5%) eyes, respectively. The predominant feature was black or grayish on NIR (34/65, 52.3%) and patchy (hypo- and hyperfluorescence was observed) on AF (25/65, 38.4%). FA and SD-OCT correctly detected mCNV in 49 (75.3%) and 48 (73.8%) eyes, respectively, whereas NIR and AF exhibited limited diagnostic sensitivity. Doubtful diagnosis was associated with hyperfluorescent mCNV (P⩽0.001), absence of retinal fluid and epiretinal membrane (P⩽0.05), and presence of macular chorioretinal atrophy (P⩽0.01).
Conclusion: Tomographic, angiographic, AF, and NIR features of mCNV are described in this study. Combination of SD-OCT and FA is recommendable for diagnosis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026213 | PMC |
http://dx.doi.org/10.2147/OPTH.S108509 | DOI Listing |
Eye (Lond)
September 2025
Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Objectives: To characterise the chorioretinal (CR) manifestations of West Nile virus (WNV) infection using multimodal imaging (MMI).
Methods: Retrospective cohort study including 37 patients with confirmed WNV infection hospitalised at a single centre (July-September 2024). All underwent comprehensive ophthalmological evaluations, including visual acuity, slit-lamp biomicroscopy, fundoscopy, and multimodal imaging: fundus photography, spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence (FAF), fluorescein angiography, and indocyanine green angiography when clinically indicated.
Sci Adv
September 2025
Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA.
Subretinal injection of adeno-associated virus (AAV) is generally more efficacious and less inflammatory than intravitreal injection for retinal gene therapy. However, adverse events (e.g.
View Article and Find Full Text PDFBr J Ophthalmol
September 2025
Robert O Curle Ophthalmology Suite, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh, UK.
Aims: To conduct the first cross-sectional epidemiological investigation of pathologic myopia (PM) in UK adults with high myopia.
Methods: Fundus photographs of 3024 highly myopic eyes (spherical equivalent refraction (SER) ≤-5.00D) from 2000 randomly sampled adults (aged 40-70 years) in the UK Biobank were double graded by an ophthalmic reading centre using the Meta-analysis for Pathologic Myopia framework.
Retin Cases Brief Rep
August 2025
Doheny Eye Institute, Pasadena, CA, USA.
Purpose: To describe the multimodal imaging features of intraretinal sclero-choroidal vessels (ISCVs) in eyes with severe chorioretinal thinning.
Methods: A retrospective observational case series. We examined 6 eyes of 6 patients with advanced chorioretinal thinning presenting to the Doheny UCLA Eye Centers (pathologic myopia with posterior staphyloma, iatrogenic staphyloma, chronic anti-VEGF exposure, or non-myopic macular atrophy).
Can J Ophthalmol
August 2025
University of Louisville, Louisville, KY, United States.